Skip to content

Clinical trials

Completed Phase 2 Major Depressive Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 2 Status: Completed Clear all

259 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20024
20038
20049
20056
20068
200716
200820
200914
201010
201113
201210
201310
201412
201510
20168
20177
201810
201910
202010
202115
202211
20239
202417
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed259

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline12
Janssen Research & Development, LLC11
Massachusetts General Hospital8
National Institute of Mental Health (NIMH)7
Alto Neuroscience6
H. Lundbeck A/S6
Otsuka Pharmaceutical Development & Commercialization, Inc.6
University of Pittsburgh6
AstraZeneca4
Icahn School of Medicine at Mount Sinai4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder259
Depressive Disorder25
Depressive Disorder, Treatment-Resistant19
Mood Disorders17
Mental Disorders10
Anxiety Disorders8
Bipolar Disorder7
Dysthymic Disorder6
Anhedonia5
Alcoholism4

Trials

Showing 1 to 25 of 259. Each trial links to its page on Pharma Observatory.

159 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.